These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 36618522)

  • 1. Galectin-3 as a Potential Biomarker of Microvascular Complications in Patients with Type 2 Diabetes.
    Kumar S; Ranawat CS; Bhandiwad C; Arya H; Mali M; Singh CP; Sharma N; Lathwal N; Wasim S
    Indian J Endocrinol Metab; 2022; 26(5):490-497. PubMed ID: 36618522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinogen Levels in Type 2 Diabetes Mellitus and it's Correlation with Microvascular Microvascular Complications.
    M RK; L H
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. To Study Relationship of Serum hsCRP with Type 2 Diabetes Mellitus, its Vascular Complications and Non-Diabetics - Case Control Study.
    Gupta R; Pamecha H
    J Assoc Physicians India; 2020 Aug; 68(8):25-29. PubMed ID: 32738836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential value of serum Progranulin as a biomarker for the presence and severity of micro vascular complications among Egyptian patients with type 2 diabetes mellitus.
    Albeltagy ES; Hammour AE; Albeltagy SA
    J Diabetes Metab Disord; 2019 Jun; 18(1):217-228. PubMed ID: 31275893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic Syndrome in Type 2 Diabetes Mellitus Patients: Prevalence, Risk Factors, and Associated Microvascular Complications.
    Asghar S; Asghar S; Shahid S; Fatima M; Bukhari SMH; Nadeem Siddiqui S
    Cureus; 2023 May; 15(5):e39076. PubMed ID: 37323312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum galectin-3: a risk factor for vascular complications in type 2 diabetes mellitus.
    Jin QH; Lou YF; Li TL; Chen HH; Liu Q; He XJ
    Chin Med J (Engl); 2013; 126(11):2109-15. PubMed ID: 23769567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants and Stratification of Microvascular Complications of Type 2 Diabetes Mellitus.
    Reddy Mallimala P; Shah K; Mirchandani M; Sharma K
    Cureus; 2023 Aug; 15(8):e44348. PubMed ID: 37779807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visceral Adiposity Index in Type 2 Diabetes Mellitus (DM) and Its Correlation With Microvascular Complications.
    Hulkoti V; Acharya S; Shukla S; Kumar S; Kabra R; Dubey A; Lahane V; Giri A
    Cureus; 2022 Nov; 14(11):e31279. PubMed ID: 36523689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of microvascular complications in patients with new diagnosis type 2 diabetes.
    Yaprak B; Keskin L
    Eur Rev Med Pharmacol Sci; 2023 Feb; 27(4):1601-1608. PubMed ID: 36876708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Galectin-3 as a prognostic biomarker for diabetic nephropathy.
    Hodeib H; Hagras MM; Abdelhai D; Watany MM; Selim A; Tawfik MA; Elsebaey MA; Elshweikh SA
    Diabetes Metab Syndr Obes; 2019; 12():325-331. PubMed ID: 30936732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do Serum Nesfatin-1 Levels have A Predictive Role in Type-2 Diabetes Mellitus and its Microvascular Complications? A Case-Control Study.
    Khalil UA; Mohamed OE; Abdullah AA; Fawzy MS; Rashad NM; Samir GM
    Cureus; 2024 Jan; 16(1):e53007. PubMed ID: 38406171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor (VEGF) in children, adolescents and young adults with Type 1 diabetes mellitus: relation to glycaemic control and microvascular complications.
    Chiarelli F; Spagnoli A; Basciani F; Tumini S; Mezzetti A; Cipollone F; Cuccurullo F; Morgese G; Verrotti A
    Diabet Med; 2000 Sep; 17(9):650-6. PubMed ID: 11051284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Galectin-3 is independently associated with progression of nephropathy in type 2 diabetes mellitus.
    Tan KCB; Cheung CL; Lee ACH; Lam JKY; Wong Y; Shiu SWM
    Diabetologia; 2018 May; 61(5):1212-1219. PubMed ID: 29417184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. To Screen for Obstructive Sleep Apnoea in Type 2 Diabetes and its Correlation with Hscrp Levels and Microvascular Complications.
    R M; Aashik ; Yadav S; Karthik
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profile of microvascular disease in type 2 diabetes in a tertiary health care hospital in India.
    Kumar HK; Kota S; Basile A; Modi K
    Ann Med Health Sci Res; 2012 Jul; 2(2):103-8. PubMed ID: 23439986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microalbuminuria as the Tip of Iceberg in Type 2 Diabetes Mellitus: Prevalence, Risk Factors, and Associated Diabetic Complications.
    Asghar S; Asghar S; Mahmood T; Bukhari SMH; Mumtaz MH; Rasheed A
    Cureus; 2023 Aug; 15(8):e43190. PubMed ID: 37692611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with glycemic control and diabetes complications in a group of Saudi patients with type 2 diabetes.
    Ewid M; Algoblan AS; Elzaki EM; Muqresh MA; Al Khalifa AR; Alshargabi AM; Alotaibi SA; Alfayez AS; Naguib M
    Medicine (Baltimore); 2023 Sep; 102(38):e35212. PubMed ID: 37747025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between serum Galectin-3 and periodontitis in patients with type 2 diabetes mellitus.
    Zhang Y; Wei M; Xia T; Yin W; Mao S
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2023 Dec; 41(6):653-661. PubMed ID: 38597030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Features and Microvascular Complications Risk Factors of Early-onset Type 2 Diabetes Mellitus.
    Huang JX; Liao YF; Li YM
    Curr Med Sci; 2019 Oct; 39(5):754-758. PubMed ID: 31612393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.